PhytoHealth Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

PhytoHealth şirketinin toplam hissedar öz sermayesi NT$2.4B ve toplam borcu NT$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla NT$2.5B ve NT$63.9M dir.

Anahtar bilgiler

Borç/özkaynak oranı

NT$0

Borç

Faiz karşılama oranı	n/a
Nakit	NT$1.36b
Eşitlik	NT$2.40b
Toplam yükümlülükler	NT$63.91m
Toplam varlıklar	NT$2.46b

Son finansal sağlık güncellemeleri

PhytoHealth (TPE:4108) Is In A Good Position To Deliver On Growth Plans

Mar 01

Recent updates

PhytoHealth (TPE:4108) Is In A Good Position To Deliver On Growth Plans

Mar 01

The PhytoHealth (TPE:4108) Share Price Has Gained 60% And Shareholders Are Hoping For More

Jan 07

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 4108 'nin kısa vadeli varlıkları ( NT$1.6B ) kısa vadeli yükümlülüklerini ( NT$45.5M ) aşıyor.

Uzun Vadeli Yükümlülükler: 4108 şirketinin kısa vadeli varlıkları ( NT$1.6B ) uzun vadeli yükümlülüklerini ( NT$18.5M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 4108 borçsuzdur.

Borcun Azaltılması: 4108 son 5 yıldır borcu bulunmamaktadır.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: 4108 şirketinin mevcut serbest nakit akışına göre 3 yıldan fazla bir süre için yeterli nakit pistine sahip olduğu belirtiliyor.

Tahmini Nakit Akışı: 4108 serbest nakit akışı her yıl % 24.6 oranında tarihsel oranda büyümeye devam ederse 3 yıldan fazla bir süre için yeterli nakit akışına sahip olur

PhytoHealth Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

PhytoHealth (TPE:4108) Is In A Good Position To Deliver On Growth Plans

Recent updates

Third quarter 2024 earnings released: NT$0.06 loss per share (vs NT$0.037 profit in 3Q 2023)

New minor risk - Market cap size

PhytoHealth Corporation Approves the Establishment of Committee for Sustainable Development

PhytoHealth Corporation to Report Q3, 2024 Results on Nov 01, 2024

Second quarter 2024 earnings released: NT$0.08 loss per share (vs NT$0.076 loss in 2Q 2023)

PhytoHealth Corporation to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: NT$0.14 loss per share (vs NT$0.037 loss in 1Q 2023)

PhytoHealth Corporation to Report Q1, 2024 Results on May 03, 2024

Full year 2023 earnings released: NT$0.24 loss per share (vs NT$0.40 loss in FY 2022)

PhytoHealth Corporation, Annual General Meeting, May 28, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: NT$0.037 (vs NT$0.02 in 3Q 2022)

New minor risk - Share price stability

PhytoHealth Corporation Announces the Resignation of Chen Wen-Hwa as Legal Representative and Director

Second quarter 2023 earnings released: NT$0.07 loss per share (vs NT$0.092 loss in 2Q 2022)

PhytoHealth Corporation Elects Wang Pai-Sen as a Director

PhytoHealth Corporation Appoints Wu Yang-Chang as Independent Director

Full year 2022 earnings released: NT$0.40 loss per share (vs NT$0.40 loss in FY 2021)

Second quarter 2022 earnings released: NT$0.10 loss per share (vs NT$0.13 loss in 2Q 2021)

First quarter 2022 earnings released: NT$0.14 loss per share (vs NT$0.14 loss in 1Q 2021)

PhytoHealth Corporation Announces R&D Progress of the One New Drugs Currently in Development

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

PhytoHealth Corporation, Annual General Meeting, May 24, 2022

Third quarter 2021 earnings released: EPS NT$0.04 (vs NT$0.18 loss in 3Q 2020)

Director & President Chien-Hsin Cheng has left the company

Second quarter 2021 earnings released: NT$0.13 loss per share (vs NT$0.018 profit in 2Q 2020)

First quarter 2021 earnings released: NT$0.14 loss per share (vs NT$0.22 loss in 1Q 2020)

PhytoHealth (TPE:4108) Is In A Good Position To Deliver On Growth Plans

Full year 2020 earnings released: NT$0.54 loss per share (vs NT$1.04 loss in FY 2019)

Phytohealth Corporation Announces Current R&D Progress on PG2, Anti-Osteoporosis, and Moderate to Severe Pain Relief New Drugs

New 90-day high: NT$30.80

The PhytoHealth (TPE:4108) Share Price Has Gained 60% And Shareholders Are Hoping For More

New 90-day high: NT$28.10

New 90-day low: NT$23.35

New 90-day low: NT$23.40

Third quarter 2020 earnings released: NT$0.18 loss per share

New 90-day low: NT$24.70

New 90-day low: NT$25.15

New 90-day low: NT$26.70

First half earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin